Product
Donor NK Cell
1 clinical trial
5 indications
Indication
Ewing SarcomaIndication
NeuroblastomaIndication
RhabdomyosarcomaIndication
OsteosarcomaIndication
Central Nervous System TumorsClinical trial
Phase 2 Solid Tumor Immunotherapy Trial Using HLA-Haploidentical Transplant and Donor Natural Killer Cells: The STIR TrialStatus: Completed, Estimated PCD: 2020-06-08